The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine
Open accessAbstract
Accumulating evidence suggests that microglial cells in the spinal cord play an important role in the development of neuropathic pain. However, it remains largely unknown how glia interact with neurons in the spinal cord after peripheral nerve injury. Recent studies suggest that the chemokine fractalkine may mediate neural/microglial interaction via its sole receptor CX3CR1. We have examined how fractalkine activates microglia in a neuropathic pain condition produced by spinal nerve ligation (SNL). SNL induced an upregulation of CX3CR1 in spinal microglia that began on day 1, peaked on day 3, and maintained on day 10. Intrathecal injection of a neutralizing antibody against CX3CR1 suppressed not only mechanical allodynia but also the activation of p38 MAPK in spinal microglia following SNL. Conversely, intrathecal infusion of fractalkine produced a marked p38 activation and mechanical allodynia. SNL also induced a dramatic reduction of the membrane-bound fractalkine in the dorsal root ganglion, suggesting a cleavage and release of this chemokine after nerve injury. Finally, application of fractalkine to spinal slices did not produce acute facilitation of excitatory synaptic transmission in lamina II dorsal horn neurons, arguing against a direct action of fractalkine on spinal neurons. Collectively, our data suggest that (a) fractalkine cleavage (release) after nerve injury may play an important role in neural-glial interaction, and (b) microglial CX3CR1/p38 MAPK pathway is critical for the development of neuropathic pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“CX3CR1 and its chemokine ligand fractalkine (CX3CL1) have been implicated in the recruitment of mononuclear phagocytes to sites of inflammation and injury (7, 10, 11) and play roles in the pathogenesis of several inflammatory conditions, including atherosclerosis (12, 13), neuropathic pain (14), and asthma (15).”
From Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice (2019) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantitative assessment of tactile allodynia in the rat paw
Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M., & Yaksh, T. L. (1994) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)90144-9 · Cited by 7,740
Ho Kim, S., & Mo Chung, J. (1992) · Pain · doi:10.1016/0304-3959(92)90041-9 · Cited by 3,069
Efficient Analysis of Experimental Observations
Dixon, W. J. (1980) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.20.040180.002301 · Cited by 2,216
Microglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645
P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury
Tsuda, M., Shigemoto‐Mogami, Y., Koizumi, S., Mizokoshi, A., Kohsaka, S., Salter, M. W., & Inoue, K. (2003) · Nature · doi:10.1038/nature01786 · Cited by 1,567
Samad, T. A., Moore, K. A., Sapirstein, A., Billet, S. E., Allchorne, A. J., Poole, S., Bonventre, J. V., & Woolf, C. J. (2001) · Nature · doi:10.1038/35068566 · Cited by 1,282
Ji, R., Samad, T. A., Jin, S., Schmoll, R., & Woolf, C. J. (2002) · Neuron · doi:10.1016/s0896-6273(02)00908-x · Cited by 1,239
Self-citationGlial activation: a driving force for pathological pain
Watkins, L. R., Milligan, E. D., & Maier, S. F. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01854-3 · Cited by 1,091
Jin, S., Zhuang, Z.-Y., Woolf, C. J., & Ji, R. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04017.2003 · Cited by 854
Self-citationVasudeva, R., Tanga, F. Y., & DeLeo, J. A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052407 · Cited by 797
Research works printed but not linked: 2
- Jin, 2002, Activation of p38 MAP kinase in the dorsal root ganglion and spinal cord after spinal nerve ligation, Soc. Neurosci. Abstr., 28, 13
- Kawasaki, 2006, Effects of proinflammatory cytokines on synaptic transmission and phosphorylation of the transcription factor CREB in dorsal horn neurons in spinal cord slices, Soc. Neurosci., 15
Cited by
Sorted by citations
Items 201–300 of 369
Diosgenin attenuates neuropathic pain in a rat model of chronic constriction injury
Zhao, W.-X., Wang, P., Song, H.-G., & Sun, N. C. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6723 · Cited by 29
Fang-Hu, Zhang, H.-H., Yang, B., Huang, J.-L., Shun, J., Kong, F., Peng-Xu, Chen, Z.-G., & Lu, J. (2015) · Brain Research · doi:10.1016/j.brainres.2015.01.056 · Cited by 28
Self-citationKiguchi, N., Ding, H., Peters, C. M., Kock, N. D., Kishioka, S., Cline, J. M., Wagner, J. D., & Ko, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.10.007 · Cited by 29
Pan, Y., Guo, Q., Wang, E., Ye, Z., He, Z.-H., Zou, W., Cheng, Z., & Wang, Y. (2010) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0b013e3181df245b · Cited by 28
Noh, C., Shin, H. J., Lee, S., Kim, S. I., Kim, S. I., Lee, W. H., Kim, D. W., Lee, S. Y., & Ko, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103469 · Cited by 28
Liu, Y., Wang, C., Wang, Q., Lin, Y., Ge, Y., Li, D., & Mao, G. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.06.012 · Cited by 26
RetractedLi, F., Xue, Z., Yuan, Y., et al. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12845 · Cited by 26
Cocea, A.-C., & Stoica, C. I. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14050537 · Cited by 32
Chou, A., Yang, M., Tsai, H., Chai, C., Tai, M., Kwan, A.-L., & Hong, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092264 · Cited by 25
Disruption of nNOS–NOS1AP protein–protein interactions suppresses neuropathic pain in mice
Lee, W.-H., Li, L., Chawla, A., Hudmon, A., Lai, Y. Y., Courtney, M. J., & Hohmann, A. G. (2018) · Pain · doi:10.1097/j.pain.0000000000001152 · Cited by 25
Li, Q., Chen, S., Liu, J., Yao, P., Duan, Y.-W., Li, Y., & Zang, Y. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02525-8 · Cited by 27
Cao, H., Zheng, J., Li, J., Meng, B., Li, J., & Ge, R.-S. (2014) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-013-1549-9 · Cited by 26
Cheng, K., Wang, H., Chang, L., Wang, F.-Y., Lai, C., Chou, C.-W., Tsai, H., & Kwan, A.-L. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-44 · Cited by 25
Xu, Q., Niu, C., Li, J., Hu, C., He, M., Qiu, X., Yao, Q., Tian, W., & Zhang, M. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-5920 · Cited by 22
Isami, K., Imai, S., Sukeishi, A., Nagayasu, K., Shirakawa, H., Nakagawa, T., & Kaneko, S. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.08.013 · Cited by 23
Yang, G., Chen, L., Gao, Z., & Wang, Y. (2018) · Molecular Pain · doi:10.1177/1744806918811238 · Cited by 23
p38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function
Perea, J. R., Bolós, M., Cuadros, R., García, E., García‐Escudero, V., Hernández, F., McManus, R. M., Heneka, M. T., & Ávila, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02715-0 · Cited by 24
Terayama, R., Fujisawa, N., Yamaguchi, D., Omura, S., Ichikawa, H., & Sugimoto, T. (2011) · Neurosciences research · doi:10.1016/j.neures.2010.11.004 · Cited by 21
New molecules for the treatment of pain
Heinzmann, S., & McMahon, S. B. (2011) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e328345bb7e · Cited by 22
Herbst, K. L., Coviello, A. D., Chang, A., & Boyle, D. L. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.119 · Cited by 23
Cao, H., Zang, K., Han, M., Zhao, Z., Wu, G.-C., & Zhang, Y. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.06.005 · Cited by 21
Zhao, P., Wang, C., & Li, W. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.04.086 · Cited by 21
Involvement of CX3CL1/CX3CR1 Signaling in Spinal Long Term Potentiation
Bian, C., Zhao, Z., Zhang, Y., & Lü, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118842 · Cited by 21
Zhao, P., De, A., Hu, Z., Li, J., Mulders, S. M., Gelpke, M. D. S., Duan, E., & Hsueh, A. J. W. (2008) · Endocrinology · doi:10.1210/en.2007-1662 · Cited by 21
Ciapała, K., & Mika, J. (2023) · Pharmaceuticals · doi:10.3390/ph16111624 · Cited by 20
Cheng, W., Zhao, Y., Liu, H., et al. (2014) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12084 · Cited by 19
Huang, Y., Wen, L.-L., Xie, J., Ouyang, H.-D., Chen, D.-T., & Zeng, W.-A. (2019) · Molecular Pain · doi:10.1177/1744806919864511 · Cited by 19
Li, D., Chen, H., Luo, X.-H., Sun, Y., Xia, W. T., & Xiong, Y.-C. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1827-y · Cited by 19
Tran, Q., Phạm, T. L., Shin, H. J., Shin, J., Shin, N., Kwon, H. H., Park, H., Kim, S. I., Choi, S. G., Wu, J., et al. (2022) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2022.102576 · Cited by 18
Hladkykh, F. V., Liadova, T., Matvieienko, M. S., Komorovsky, R., Smiyan, S., & Student, V. (2026) · Journal of Pain Research · doi:10.2147/jpr.s571311 · Cited by 22
Proinflammatory cytokines and their receptors as druggable targets to alleviate pathological pain
Kalpachidou, T., Riehl, L., Schöpf, C. L., Uçar, B., & Kress, M. (2022) · Pain · doi:10.1097/j.pain.0000000000002737 · Cited by 17
Zhang, T., Liang, W., Zhang, M., Cui, S., Huang, X., Ou, W., Huang, R., Gao, J., Jia, Z., & Zhang, S. (2023) · Pharmaceuticals · doi:10.3390/ph16020243 · Cited by 18
Liu, N., Zhang, G., Zhu, C., Lan, X., Tian, M., Zheng, P., Peng, X.-D., Li, Y., & Yu, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115675 · Cited by 17
Yang, F., Peng, L., Luo, J., Yi, H., & Hu, X. (2016) · Peptides · doi:10.1016/j.peptides.2016.05.005 · Cited by 17
Increase in hemokinin‐1 mRNA in the spinal cord during the early phase of a neuropathic pain state
Matsumura, T., Sakai, A., Nagano, M., et al. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.301 · Cited by 16
Wang, S., Song, L., Tan, Y., et al. (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2012.01511.x · Cited by 16
Neuron–microglia interactions modulating neuropathic pain
Kohno, K., & Tsuda, M. (2025) · International Immunology · doi:10.1093/intimm/dxaf022 · Cited by 18
Zhang, X., Pengcheng, X., Li, C., Zhu, W., Wu, S., Yu, A., Ding, Y., Wang, Q., & Zhang, Z. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000769 · Cited by 16
田中, 義., Hu, Z., Wu, J., Dai, F., Lee, F., & Xu, Y. (2020) · Oncology Reports · doi:10.3892/or.2020.7769 · Cited by 16
Chen, Y., Huang, C., Liu, H.-Y., Yao, W., Wu, W., Lu, Y., & Wang, W. (2016) · British Journal of Biomedical Science · doi:10.1080/09674845.2016.1209897 · Cited by 16
Cathepsin S as a potential therapeutic target for chronic pain
Montague-Cardoso, K., & Malcangio, M. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100047 · Cited by 15
Mesnard, N. A., Alexander, T. D., Sanders, V. M., et al. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.05.019 · Cited by 14
Bressan, E., Peres, K. C., & Tonussi, C. R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.09.028 · Cited by 14
Differential Gene Expression in the Axotomized Facial Motor Nucleus of Presymptomatic SOD1 Mice
Mesnard, N., Sanders, V. M., & Jones, K. (2011) · The Journal of comparative neurology · doi:10.1002/cne.22718 · Cited by 14
A state-of-the-art perspective on microgliopathic pain
Inoue, K. (2018) · Open Biology · doi:10.1098/rsob.180154 · Cited by 16
Long noncoding RNA LOC100911498 is a novel regulator of neuropathic pain in rats
Tang, W., Zhang, L., & Li, Z. (2021) · Brain and Behavior · doi:10.1002/brb3.1966 · Cited by 14
Zhang, Z., Niu, Z., & Dong, S. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106404 · Cited by 18
Reorganization of synaptic inputs to spinal dorsal horn neurons in neuropathic pain
Terayama, R., & Uchibe, K. (2021) · International Journal of Neuroscience · doi:10.1080/00207454.2021.1873980 · Cited by 13
Mountford, J., Octaviana, F., Estiasari, R., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001714 · Cited by 13
Aldossari, A. A., Ansari, M. A., Nadeem, A., Attia, S. M., Bakheet, S. A., AL-Ayadhi, L. Y., Alanazi, M. M., Shahid, M., Alwetaid, M. Y., Hussein, M. H., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087475 · Cited by 13
Cairns, B. E., O’Brien, M. S., Dong, X., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9935-x · Cited by 13
Gene therapy for chronic neuropathic pain: how does it work and where do we stand today?
Kumar, S., Ruchi, R., James, S. R., & Chidiac, E. (2011) · Pain medicine (Malden, Mass.) · doi:10.1111/j.1526-4637.2011.01120.x · Cited by 14
Macrophage: A key player in neuropathic pain
Ye, Y., Cheng, H., Wang, Y., Sun, Y., Zhang, L., & Tang, J. (2024) · International Reviews of Immunology · doi:10.1080/08830185.2024.2344170 · Cited by 13
Gene-based approaches in pain research and exploration of new therapeutic targets and strategies.
Molet, J., & Pohl, M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.073 · Cited by 15
Chen, J., Ding, H., Liu, B., Zhou, X., Zhou, X. J., Lin, Z., Yang, F., Zhan, H., & Xiao, H. (2021) · Mediators of Inflammation · doi:10.1155/2021/1791222 · Cited by 12
Retamal, J. S., Reyes, A., Ramírez-García, P. D., Bravo, D., Hernández, A., Pélissier, T., Villanueva, L., & Constandil, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01143 · Cited by 12
Cytochrome P450 26A1 Contributes to the Maintenance of Neuropathic Pain
Cao, D., Ma, L.-J., Jiang, B., Gu, Q., & Gao, Y. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01101-1 · Cited by 12
The Role of Fractalkine in Diabetic Retinopathy: Pathophysiology and Clinical Implications
Lee, C.-Y., & Yang, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010378 · Cited by 11
Targeting Chemokines and Chemokine GPCRs to Enhance Strong Opioid Efficacy in Neuropathic Pain
Vincenzi, M., Milella, M. S., D’Ottavio, G., Caprioli, D., Reverte, I., & Maftei, D. (2022) · Life · doi:10.3390/life12030398 · Cited by 11
Cerebrospinal fluid-contacting nucleus mediates nociception via release of fractalkine
Zhou, Q. Q., Chen, S. S., Zhang, Q. Q., Liu, P. F., Fang, H. Z., Yang, Y., & Zhang, L. C. (2017) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20176275 · Cited by 11
Up-Regulation of CX3CL1 via STAT3 Contributes to SMIR-Induced Chronic Postsurgical Pain
Shen, Y., Li, D., Li, B., Peng, X., Zhang, Y., Jiang, Y.-S., Xu, Y., Chen, H., & Xiong, Y.-C. (2018) · Neurochemical Research · doi:10.1007/s11064-017-2449-8 · Cited by 12
Role of Endocannabinoids in Neuron-Glial Crosstalk
Luongo, L., Palazzo, E., de Novellis, V., & Maione, S. (2010) · The Open Pain Journal · doi:10.2174/1876386301003010029 · Cited by 11
Wang, Y., Xue, M., Xia, Y.-Y., Jiang, Q., Huang, Z.-H., & Huang, C. (2020) · Pain Research and Management · doi:10.1155/2020/1854363 · Cited by 10
Huang, Y. L., Su, M., Zhang, C., Zhan, H., Yang, F., Gao, Z., Zhou, X., & Liu, B. (2022) · European Journal of Pain · doi:10.1002/ejp.1942 · Cited by 10
Spinal CX3CL1/CX3CR1 May Not Directly Participate in the Development of Morphine Tolerance in Rats
Peng, Y.-W., Guo, G., Shu, B., Liu, D.-Q., Su, P., Zhang, X., & Gao, F. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2364-z · Cited by 9
Gene Expression Profiling of Cx3cl1 in Bone Marrow Mesenchymal Stem Cells by Osteogenic Induction
Xiao, J., Dong, H. Y., Wu, Y., et al. (2009) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2009.0018 · Cited by 10
Glial Mechanisms of Neuropathic Pain and Emerging Interventions
Jo, D. H., Chapman, C. R., & Light, A. R. (2009) · The Korean journal of pain · doi:10.3344/kjp.2009.22.1.1 · Cited by 10
Wang, L., Zhao, S., Shao, J., & Su, C. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149117 · Cited by 11
Chemokine CCL2 Mediates Neuroglial Crosstalk and Drives Chronic Pain Pathogenesis
Lu, J., Shi, Y., Li, Y., Niu, Z., Wu, S., Luo, C., & Xie, R. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01519-9 · Cited by 10
Al-HadlaQ, M. W., & Masocha, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612805 · Cited by 9
Molecular Changes Involving MEK3–p38 MAPK Activation in Chronic Masticatory Myalgia
Meng, H., Gao, Y., Kang, Y. F., Zhao, Y., Yang, G. J., Wang, Y., Cao, Y., Gan, Y.-H., & Xie, Q. F. (2016) · Journal of Dental Research · doi:10.1177/0022034516659441 · Cited by 9
Maixner, D. W., Yan, X., Hooks, S. B., & Weng, H. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.03.061 · Cited by 9
Baloui, H., Stettler, O., Weiss, S. F. T., Nothias, F., & von Boxberg, Y. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0677 · Cited by 9
Inflammatory Mediators, Nociceptors, and Their Interactions in Pain
Ji, J., Huh, Y., & Ji, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-29231-6_4 · Cited by 8
Self-citationNiu, Z., Bao, L., & Chen, J. (2022) · PubMed · doi:10.14670/hh-18-405 · Cited by 8
Chase, R., de la Peña, J. B., Smith, P. R., Lawson, J. M., Lou, T., Stanowick, A. D., Black, B. J., & Campbell, Z. T. (2022) · The FASEB Journal · doi:10.1096/fj.202101933rr · Cited by 8
Wang, D., Xue, Y., Yan, Y., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.03.020 · Cited by 8
Self-citationQi, Y., Liu, L., Liang, D., Tang, S., Yu, X., Ye, H., & Chen, N. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154828 · Cited by 7
Bibliometric and visual analysis of microglia-related neuropathic pain from 2000 to 2021
Zhang, S.-B., Zhao, G., Lv, T.-R., Gong, C.-Y., Shi, Y., Nan, W., & Zhang, H. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1142852 · Cited by 7
Yang, Y., Mou, B., Zhang, Q., Zhao, H., Zhang, J., Yun, X. Y., Xiong, M., Liu, Y., Liu, Y., Pan, H., et al. (2022) · Glia · doi:10.1002/glia.24438 · Cited by 7
Hsu, S.-F., Zeng, Y.-J., Tsai, S.-Y., et al. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.01.035 · Cited by 7
Self-citationPike, C., Kim, M., Schnitzer, K., Mercaldo, N. D., Edwards, R. R., Napadow, V., Zhang, Y., Morrissey, E. J., Alshelh, Z., Evins, A. E., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-063613 · Cited by 7
Jacobsen, D. P., Moen, A., Haugen, F., et al. (2016) · International Journal of Inflammation · doi:10.1155/2016/6519408 · Cited by 7
Wang, Y., Niu, Y., Lin, F., Su, P., Chen, L., Liu, D., & Sun, Y. A. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-01975-2 · Cited by 6
CXCR3 signalling partially contributes to the pathogenesis of neuropathic pain in male rodents
Li, K., Tan, Y., Feng, S., & Fu, K. (2021) · Journal of Oral Rehabilitation · doi:10.1111/joor.13262 · Cited by 6
Chronic Pain: Epidemiology, Pathophysiology, and Clinical Management
Shang, Z., Tian, Z., Wang, Z., Yang, Z., Wang, Z., Wang, Z., Wang, Z., He, X., Yu, Y., Gong, Y., et al. (2026) · MedComm · doi:10.1002/mco2.70756 · Cited by 5
Sun, Y., Liu, J., & Tian, F. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6581 · Cited by 5
The Role of Spinal Cord CX3CL1/CX3CR1 Signalling in Chronic Pain
Montague-Cardoso, K., Mrózková, P., & Malcangio, M. (2020) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-020-00006-9 · Cited by 5
Decoding chronic pain: insights into the transition from acute to persistent pain
Wadhwa, K., Chauhan, P., Singh, G., Jha, S. K., Almutary, A. G., & Jha, N. K. (2025) · Open Biology · doi:10.1098/rsob.240234 · Cited by 5
Glial cells in neuropathic pain
Berta, T., Khoutorsky, A., Xu, J., & Ji, R. (2026) · Physiological Reviews · doi:10.1152/physrev.00034.2025 · Cited by 7
Self-citationThe Ambivalent Role of Glial Cells in Neuroinflammation and Neuropathic Pain
Shanti, B. F., Shanti, I. F., Al-Abbadi, K., Rjoub, A. A., & Otom, A. H. (2020) · Acta Scientific Neurology · doi:10.31080/asne.2020.03.0195 · Cited by 3
Mecanismos del dolor neuropático: Del laboratorio a la clínica
Gómez-Barrios, J. V., & Tortorici, V. (2009) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 3
The novel therapeuthic targets in the treatment of chronic pain.
Palomba, R., Bonaccia, P., Graffi, M., & Costa, F. (2012) · Europe PMC (PubMed Central) · Cited by 3
RetractedSzeredi, I. D., Jancsó, G., Oszlács, O., et al. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03285-8 · Cited by 3
Üçeyler, N., & Sommer, C. (2008) · Der Schmerz · doi:10.1007/s00482-008-0706-0 · Cited by 3
De nouvelles perspectives pour les chimiokines
Rostène, W. H. (2010) · Biologie Aujourd hui · doi:10.1051/jbio/2010020 · Cited by 3
Wang, A., Tie, M., Guo, D., et al. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01455-0 · Cited by 3
Spinal plasticity of the nociceptive system
Latrémolière, A. (2016) · Wiley eBooks · doi:10.1002/9781118455968.ch2 · Cited by 4
Ridehalgh, C., Fundaun, J., & Farrell, S. F. (2025) · Musculoskeletal Science and Practice · doi:10.1016/j.msksp.2025.103468 · Cited by 2
Cognitive and transcriptomic effects of Epigallocatechin gallate in fetal alcohol spectrum disorders
Ramos-Triguero, A., Astals, M., Navarro‐Tapia, E., Vieiros, M., Bastons-Compta, A., Martínez, L., Andreu-Férnández, V., & García‐Algar, Ó. (2026) · Scientific Reports · doi:10.1038/s41598-025-34576-1 · Cited by 2
Metadata
- Authors
- Zhuang, Z.-Y., Kawasaki, Y., Tan, P.-H., Wen, Y.-R., Huang, J., & Ji, R.-R.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Ji, Ru-Rong
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 21
- Issue
- 5
- Pages
- 642-651
- ISSN
- 0889-1591 (ISSN-L)
- PMC
- PMC2084372
- OpenAlex
- W2006680088
- Semantic Scholar
- 64f3a09c34ad12759b6e063e279570703bf27e54
- Cited by
- 371
- References
- 51
- Citations by year
- 2026: 14 · 2025: 7 · 2024: 5 · 2023: 19 · 2022: 17 · 2021: 19 · 2020: 26 · 2019: 15 · 2018: 26 · 2017: 17 · 2016: 24 · 2015: 16 · 2014: 25 · 2013: 23 · 2012: 17
- FWCI
- 12.15
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain Behavior and Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- Fogarty International Center (R03TW007180)
- National Institute of Neurological Disorders and Stroke (R01NS040698)
- National Institute of Dental and Craniofacial Research (R01DE017794, R01 DE17794)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Keywords
- neuropathic pain, spinal microglia, CX3CR1, fractalkine, p38 MAPK, spinal nerve ligation, mechanical allodynia, dorsal root ganglia, microglial activation, excitatory synaptic transmission
- MeSH terms
- CX3C Chemokine Receptor 1, Analysis of Variance, Animals, Disease Models, Animal, Ligation, Male, Membrane Proteins, Neuralgia, Spinal Cord, Spinal Nerves, Signal Transduction, Rats, Sprague-Dawley, Pain Threshold, Microglia, Statistics, Nonparametric, Receptors, Chemokine, Chemokines, CX3C, Posterior Horn Cells, p38 Mitogen-Activated Protein Kinases, Rats, Chemokine CX3CL1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review